|
|
Article: Echo health - Kidney cancer lifeline denied to Scots, too
- Article from:
- The Northern Echo
- Article date:
- July 13, 2007
- Author:
CopyrightCopyright 2007 The Northern Echo. Provided by ProQuest LLC. (Hide copyright information)
|
RESTRICTIONS on a life-extending new drug for kidney cancer
patients have been extended to Scotland. Health service providers in
Scotland have been told not to fund the [pounds
]23,000-a-year drug
Sutent because it fails the cost effectiveness test.The same drug has
been denied to a number of patients in the North-East.Last week The
Northern Echo highlighted the contrasting fortunes of two advanced
kidney cancer patients, Kathleen Devonport, 63, from Chilton, County
Durham and Barbara Selby, from Richmond, North Yorkshire.Mrs
Devonport has been able to have treatment after an anonymous
wellwisher donated [pounds
Related newspaper, magazine, and journal articles:
|
|
Article: Drugs U-turn brings kidney cancer boost
The Scotsman;
March 25, 2009 ;
661 words
... ... interferon-alpha, was available for advanced kidney cancer, but many patients do not respond well to it. James Whale, chairman of the James Whale Fund for Kidney Cancer, said: "Finally we have justice. This ...
|
|